World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
37245
World Ranking
11607
National Ranking
624

Overview

Joachim Listing is affiliated with the Leibniz Institute for Neurobiology in Germany and has dedicated their research primarily to the field of medicine, with a focus on rheumatology. Their work spans related subfields such as hematology, pharmacology, immunology, and clinical psychology.

Their recent publications demonstrate involvement in clinical trials and observational studies addressing autoimmune and inflammatory disorders, as well as treatments targeting rheumatic diseases. Notable papers include:

  • Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial (2020, Annals of the Rheumatic Diseases)
  • Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial (2021, RMD Open)
  • Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial (2024, Annals of the Rheumatic Diseases)
  • Implementing an automated monitoring process in a digital, longitudinal observational cohort study (2021, Arthritis Research & Therapy)
  • Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still's Disease and Active Articular Manifestation Responding to Canakinumab (2021, Journal of Clinical Medicine)

Joachim Listing frequently collaborates with a group of researchers, including:

  • Joachim Sieper
  • Claudia Kedor
  • Fabian Proft
  • Valeria Ríos Rodríguez
  • Mikhail Protopopov

Their publications are commonly found in several medical journals such as:

  • Annals of the Rheumatic Diseases
  • RMD Open
  • Arthritis Research & Therapy
  • Journal of Clinical Medicine
  • The Journal of Rheumatology

The research topics covered by Joachim Listing include:

  • Spondyloarthritis Studies and Treatments
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Otitis Media and Relapsing Polychondritis
  • Pharmacological Effects of Natural Compounds
  • Psoriasis: Treatment and Pathogenesis
  • Inflammatory mediators and NSAID effects

Joachim Listing's work advances knowledge on the pharmacological and clinical aspects of rheumatic diseases, particularly in relation to immunological mechanisms and therapeutic interventions involving biologics and anti-inflammatory agents.

Best Publications

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    M Rudwaleit;D van der Heijde;R Landewé;J Listing

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    J Braun;J Brandt;J Listing;A Zink

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Infections in patients with rheumatoid arthritis treated with biologic agents.

    Joachim Listing;Anja Strangfeld;Sonja Kary;Rolf Rau

  • The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

    Martin Rudwaleit;Hildrun Haibel;Xenofon Baraliakos;Joachim Listing

  • ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

    D van der Heijde;E Lie;T K Kvien;J Sieper

  • Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

    Anja Strangfeld;Joachim Listing;Peter Herzer;Anke Liebhaber

  • Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

    Martin Rudwaleit;Anke Metter;Joachim Listing;Joachim Sieper

  • Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis

    J. Brandt;A. Khariouzov;J. Listing;H. Haibel

  • The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    Joachim Listing;Kerstin Gerhold;Angela Zink

  • Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

    Martin Rudwaleit;Joachim Listing;Jan Brandt;Jürgen Braun

  • Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

    J. Braun;X. Baraliakos;W. Golder;J. Brandt

  • Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

    Denis Poddubnyy;Hildrun Haibel;Joachim Listing;Elisabeth Märker-Hermann

  • Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    J. Braun;X. Baraliakos;J. Listing;J. Sieper

  • Long-term outcome in patients with juvenile idiopathic arthritis.

    Kirsten Minden;Martina Niewerth;Joachim Listing;Thomas Biedermann

  • Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

    A Zink;J Braun;J Listing;J Wollenhaupt

  • Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    A Strangfeld;M Eveslage;M Schneider;H J Bergerhausen

  • Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

    Denis Poddubnyy;Martin Rudwaleit;Hildrun Haibel;Joachim Listing

  • Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two†

    Hildrun Haibel;Martin Rudwaleit;Joachim Listing;Frank Heldmann

Frequent Co-Authors

Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Xenofon Baraliakos
Xenofon Baraliakos Ruhr University Bochum
Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Martin Rudwaleit
Martin Rudwaleit Ghent University
Robert Landewé
Robert Landewé University of Amsterdam
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Johan Askling
Johan Askling Karolinska Institute
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Paul Emery
Paul Emery University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to numerous allied health fields and online degree options. For those interested in patient care but looking for an alternative entry path, consider exploring a nursing school without teas test requirements, which can streamline your path into nursing.

Another popular and versatile option is to pursue a degree in healthcare administration. This direction is ideal for students interested in hospital management, leadership, or healthcare policy, and many programs are now available fully online for maximum flexibility.

If you are a nurse seeking advanced practice, consider programs designed for career progression, such as specialized adn to np bridge programs. These accelerated pathways help registered nurses quickly move towards nurse practitioner roles.

For those interested in disease prevention and wellness, pursuing online nutrition degrees can lead to careers in dietary counseling, education, and community health. Each of these online programs can complement or offer alternatives to traditional medical studies.

Best Scientists Citing Joachim Listing

Trending Scientists